Scott M. Wunsch - 08 Jun 2026 Form 4/A - Amendment Insider Report for Strata Critical Medical, Inc. (SRTA)

Reporting relationship: CEO, Logistics
Issuer ticker: SRTA
Reported as of: 08 Jun 2026
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 18 Jun 2026, 16:09:58 UTC
Original report date: 10 Jun 2026
Prior SEC filing: 27 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Melissa M. Tomkiel, Attorney-in-fact for Scott M. Wunsch

Key filing fact

Scott M. Wunsch filed Form 4/A - Amendment for Strata Critical Medical, Inc. (SRTA) on 18 Jun 2026.

Key facts

This page summarizes Scott M. Wunsch's Form 4/A - Amendment filing for Strata Critical Medical, Inc. (SRTA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 Jun 2026, 16:09.

Change

Previous filing in this sequence was filed on 27 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0002027324 Primary reporting owner

Wunsch Scott M

Relationship: CEO, Logistics
Address: C/O STRATA CRITICAL MEDICAL, INC., 666 THIRD AVENUE, 25TH FLOOR, NEW YORK
Signature: /s/ Melissa M. Tomkiel, Attorney-in-fact for Scott M. Wunsch
Signature date: 18 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SRTA transaction

Class A common stock, $0.0001 par value per share

Tax liability

Transaction value
Shares: -5,550
Change %: -0.88%
Price: $5.87^*
Shares after: 625,574
Date: 08 Jun 2026
Ownership: Direct
Footnotes: F1, F2

SRTA holding

Class A common stock, $0.0001 par value per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 382,987
Date: 08 Jun 2026
Ownership: See Footnotes
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On June 10, 2026, the reporting person filed a Form 4 (the "Original Form") which inadvertently used the "S" code in Column 3 of Table I in connection with the disposal of certain shares of the Issuer's Class A common stock (the "Shares") on June 8, 2026. The Shares were in fact withheld by the Issuer to satisfy tax withholding obligations in connection a vesting event in a transaction approved in accordance with Rule 16b-3 of the Securities Exchange Act of 1934, as amended. Footnote 1 to the Original Form correctly described the transaction as "shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units." Accordingly, the reporting person is hereby amending the Original Form to correctly show the "F" code in Column 3 of Table I. The information set forth in the Original Form was correct in all other respects.

Footnote F2

Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Footnote F3

Held directly by a limited liability company of which the Reporting Person is the sole member.